Clinical Trials Browser

Phase 2/3 × Sirolimus × Gastrointestinal × Clear all

NCT07165886 2025-09-10

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Phase 2/3 Recruiting

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Phase 2/3 Terminated

130 enrolled 13 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00328770 2013-06-24

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Phase 2/3 Completed

70 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular